The French National Authority for Health (HAS) released new set of decisions in relation to add-on reimbursement of medical devices in August

06

Sep 2017

French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in August 2017. They include different types of stents and stent-grafts for multiple indications (coronary, peripheral vascular), mechanical thrombectomy devices for stroke, medical devices applied for treatment of ulcer of venous origin, remote monitoring for Implantable Cardioverter Defibrillator Systems (ICDS):

  • Two decisions in relation to coronary stents and balloons:
    • PANTERA LUX, coronary paclitaxel-releasing balloon (application for registration, approved only for two of three proposed indications/ first restenosis after stenting procedure with bare metal stents or drug-eluting stents)
    • COROFLEX ISAR NEO, coronary drug-eluting stent (application for registration, approved)
  • Two decisions for peripheral vascular stent and drug-coated balloon:
    • GORE VIABAHN, peripheral vascular stent (request for amendment + renewal of registration, approved)
    • LUTONIX 035, peripheral vascular paclitaxel-releasing balloon (application for registration, approved)
  • Three decisions for medical devices applied for intracranial thrombectomy:
  • Two decisions for devices ulcer of venous origin:

Additionally, HAS approved 15 applications for renewal of registration of systems for remote monitoring for Implantable Cardioverter Defibrillator Systems (ICDS) that manufactured by five medtech companies:

Other decisions of CNEDiMTS in August include:

See list of decisions here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

24

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Read more

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more